Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Microbial Biomarkers of Intestinal Barrier Maturation in Preterm Infants.

Ma B, McComb E, Gajer P, Yang H, Humphrys M, Okogbule-Wonodi AC, Fasano A, Ravel J, Viscardi RM.

Front Microbiol. 2018 Nov 14;9:2755. doi: 10.3389/fmicb.2018.02755. eCollection 2018.

2.

Impact of red blood cell transfusions on intestinal barrier function in preterm infants.

Ajayi OO, Davis NL, Saleem B, Kapoor S, Okogbule-Wonodi AC, Viscardi RM, Sundararajan S.

J Neonatal Perinatal Med. 2019;12(1):95-101. doi: 10.3233/NPM-1828.

PMID:
30412507
3.

Cerebral autoregulation in premature infants during the first 96 hours of life and relationship to adverse outcomes.

Hoffman SB, Cheng YJ, Magder LS, Shet N, Viscardi RM.

Arch Dis Child Fetal Neonatal Ed. 2018 Nov 1. pii: fetalneonatal-2018-315725. doi: 10.1136/archdischild-2018-315725. [Epub ahead of print]

PMID:
30385514
4.

Bronchopulmonary Dysplasia: Executive Summary of a Workshop.

Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, Ryan RM, Kallapur SG, Steinhorn RH, Konduri GG, Davis SD, Thebaud B, Clyman RI, Collaco JM, Martin CR, Woods JC, Finer NN, Raju TNK.

J Pediatr. 2018 Jun;197:300-308. doi: 10.1016/j.jpeds.2018.01.043. Epub 2018 Mar 16. No abstract available.

5.

Intestinal Barrier Maturation in Very Low Birthweight Infants: Relationship to Feeding and Antibiotic Exposure.

Saleem B, Okogbule-Wonodi AC, Fasano A, Magder LS, Ravel J, Kapoor S, Viscardi RM.

J Pediatr. 2017 Apr;183:31-36.e1. doi: 10.1016/j.jpeds.2017.01.013. Epub 2017 Jan 31.

6.

Enhanced allergic responsiveness after early childhood infection with respiratory viruses: Are long-lived alternatively activated macrophages the missing link?

Keegan AD, Shirey KA, Bagdure D, Blanco J, Viscardi RM, Vogel SN.

Pathog Dis. 2016 Jul;74(5). pii: ftw047. doi: 10.1093/femspd/ftw047. Epub 2016 May 12.

7.

The Objective Use of Pulse Oximetry to Predict Respiratory Support Transition in Preterm Infants: An Observational Pilot Study.

Mascoll-Robertson KK, Viscardi RM, Woo HC.

Respir Care. 2016 Apr;61(4):416-22. doi: 10.4187/respcare.04102. Epub 2016 Jan 12.

8.

Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update.

Viscardi RM, Kallapur SG.

Clin Perinatol. 2015 Dec;42(4):719-38. doi: 10.1016/j.clp.2015.08.003. Epub 2015 Oct 9. Review.

9.

Antenatal factors modulate hearing screen failure risk in preterm infants.

Leung JC, Cifra CL, Agthe AG, Sun CC, Viscardi RM.

Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F56-61. doi: 10.1136/archdischild-2014-307843. Epub 2015 Jul 20.

PMID:
26195624
10.

Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.

Merchan LM, Hassan HE, Terrin ML, Waites KB, Kaufman DA, Ambalavanan N, Donohue P, Dulkerian SJ, Schelonka R, Magder LS, Shukla S, Eddington ND, Viscardi RM.

Antimicrob Agents Chemother. 2015 Jan;59(1):570-8. doi: 10.1128/AAC.03951-14. Epub 2014 Nov 10.

11.

Pharmacological options for BPD prevention: steps for better clinical trial design.

Viscardi RM.

J Perinatol. 2014 Sep;34(9):656-7. doi: 10.1038/jp.2014.130. No abstract available.

PMID:
25179379
12.

Glucose monitoring in neonates: need for accurate and non-invasive methods.

Woo HC, Tolosa L, El-Metwally D, Viscardi RM.

Arch Dis Child Fetal Neonatal Ed. 2014 Mar;99(2):F153-7. doi: 10.1136/archdischild-2013-304682. Epub 2013 Sep 24. Review.

PMID:
24065727
13.

Ureaplasma species: role in neonatal morbidities and outcomes.

Viscardi RM.

Arch Dis Child Fetal Neonatal Ed. 2014 Jan;99(1):F87-92. doi: 10.1136/archdischild-2012-303351. Epub 2013 Aug 19. Review.

14.

Single nucleotide polymorphism in toll-like receptor 6 is associated with a decreased risk for ureaplasma respiratory tract colonization and bronchopulmonary dysplasia in preterm infants.

Winters AH, Levan TD, Vogel SN, Chesko KL, Pollin TI, Viscardi RM.

Pediatr Infect Dis J. 2013 Aug;32(8):898-904. doi: 10.1097/INF.0b013e31828fc693.

15.

Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.

Viscardi RM, Othman AA, Hassan HE, Eddington ND, Abebe E, Terrin ML, Kaufman DA, Waites KB.

Antimicrob Agents Chemother. 2013 May;57(5):2127-33. doi: 10.1128/AAC.02183-12. Epub 2013 Feb 25.

16.
17.

Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates.

Pandelidis K, McCarthy A, Chesko KL, Viscardi RM.

Pediatr Infect Dis J. 2013 Apr;32(4):394-8. doi: 10.1097/INF.0b013e3182791ae0.

18.

Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.

Waites KB, Xiao L, Paralanov V, Viscardi RM, Glass JI.

J Mol Diagn. 2012 Sep;14(5):437-50. doi: 10.1016/j.jmoldx.2012.06.001. Epub 2012 Jul 20. Review.

19.

IL-18R1 and IL-18RAP SNPs may be associated with bronchopulmonary dysplasia in African-American infants.

Floros J, Londono D, Gordon D, Silveyra P, Diangelo SL, Viscardi RM, Worthen GS, Shenberger J, Wang G, Lin Z, Thomas NJ.

Pediatr Res. 2012 Jan;71(1):107-14. doi: 10.1038/pr.2011.14.

20.

Perinatal inflammation and lung injury.

Viscardi RM.

Semin Fetal Neonatal Med. 2012 Feb;17(1):30-5. doi: 10.1016/j.siny.2011.08.002. Epub 2011 Sep 8. Review.

21.

NICU admission hypothermia, chorioamnionitis, and cytokines.

Fairchild KD, Sun CC, Gross GC, Okogbule-Wonodi AC, Chasm RM, Viscardi RM.

J Perinat Med. 2011 Nov;39(6):731-6. doi: 10.1515/JPM.2011.078. Epub 2011 Aug 13.

22.

Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

Cole LE, Mann BJ, Shirey KA, Richard K, Yang Y, Gearhart PJ, Chesko KL, Viscardi RM, Vogel SN.

J Leukoc Biol. 2011 Oct;90(4):787-97. doi: 10.1189/jlb.0111014. Epub 2011 Jul 12.

23.

Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants.

Okogbule-Wonodi AC, Gross GW, Sun CC, Agthe AG, Xiao L, Waites KB, Viscardi RM.

Pediatr Res. 2011 May;69(5 Pt 1):442-7. doi: 10.1203/PDR.0b013e3182111827.

24.

Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia.

Sung TJ, Xiao L, Duffy L, Waites KB, Chesko KL, Viscardi RM.

Pediatr Infect Dis J. 2011 May;30(5):379-83. doi: 10.1097/INF.0b013e318202ac3a.

25.

Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.

Hassan HE, Othman AA, Eddington ND, Duffy L, Xiao L, Waites KB, Kaufman DA, Fairchild KD, Terrin ML, Viscardi RM.

J Clin Pharmacol. 2011 Sep;51(9):1264-75. doi: 10.1177/0091270010382021. Epub 2010 Nov 23.

26.

Ureaplasma species: role in diseases of prematurity.

Viscardi RM.

Clin Perinatol. 2010 Jun;37(2):393-409. doi: 10.1016/j.clp.2009.12.003. Review.

27.

Surfactant protein-A enhances ureaplasmacidal activity in vitro.

Okogbule-Wonodi AC, Chesko KL, Famuyide ME, Viscardi RM.

Innate Immun. 2011 Apr;17(2):145-51. doi: 10.1177/1753425909360552. Epub 2010 Mar 2.

PMID:
20197455
28.

Surfactant protein-A limits Ureaplasma-mediated lung inflammation in a murine pneumonia model.

Famuyide ME, Hasday JD, Carter HC, Chesko KL, He JR, Viscardi RM.

Pediatr Res. 2009 Aug;66(2):162-7. doi: 10.1203/PDR.0b013e3181aabd66.

29.

Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence.

Viscardi RM, Hasday JD.

Pediatr Res. 2009 May;65(5 Pt 2):84R-90R. doi: 10.1203/PDR.0b013e31819dc2f9. Review.

30.

Infant neurodevelopment following fetal growth restriction: relationship with antepartum surveillance parameters.

Baschat AA, Viscardi RM, Hussey-Gardner B, Hashmi N, Harman C.

Ultrasound Obstet Gynecol. 2009 Jan;33(1):44-50. doi: 10.1002/uog.6286.

31.

Incidence of invasive ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage.

Viscardi RM, Hashmi N, Gross GW, Sun CC, Rodriguez A, Fairchild KD.

J Perinatol. 2008 Nov;28(11):759-65. doi: 10.1038/jp.2008.98. Epub 2008 Jul 3.

32.

Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung.

Viscardi RM, Atamas SP, Luzina IG, Hasday JD, He JR, Sime PJ, Coalson JJ, Yoder BA.

Pediatr Res. 2006 Aug;60(2):141-6.

PMID:
16864693
33.

Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants.

Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun CC, Gross GW, Campbell AB, Wilson PD, Hester L, Hasday JD.

Pediatr Res. 2004 Jun;55(6):1009-17.

PMID:
15155869
34.

Hypothermia prolongs activation of NF-kappaB and augments generation of inflammatory cytokines.

Fairchild KD, Singh IS, Patel S, Drysdale BE, Viscardi RM, Hester L, Lazusky HM, Hasday JD.

Am J Physiol Cell Physiol. 2004 Aug;287(2):C422-31. Epub 2004 Apr 7.

35.

Febrile-range hyperthermia augments pulmonary neutrophil recruitment and amplifies pulmonary oxygen toxicity.

Hasday JD, Garrison A, Singh IS, Standiford T, Ellis GS, Rao S, He JR, Rice P, Frank M, Goldblum SE, Viscardi RM.

Am J Pathol. 2003 Jun;162(6):2005-17.

36.

Characterization of a murine model of Ureaplasma urealyticum pneumonia.

Viscardi RM, Kaplan J, Lovchik JC, He JR, Hester L, Rao S, Hasday JD.

Infect Immun. 2002 Oct;70(10):5721-9.

37.

Discrepancy in pathologic diagnosis of placental lesions.

Sun CC, Revell VO, Belli AJ, Viscardi RM.

Arch Pathol Lab Med. 2002 Jun;126(6):706-9.

PMID:
12033960
38.

Antenatal prediction of intraventricular hemorrhage in fetal growth restriction: what is the role of Doppler?

Baschat AA, Gembruch U, Viscardi RM, Gortner L, Harman CR.

Ultrasound Obstet Gynecol. 2002 Apr;19(4):334-9.

39.

Lung pathology in premature infants with Ureaplasma urealyticum infection.

Viscardi RM, Manimtim WM, Sun CC, Duffy L, Cassell GH.

Pediatr Dev Pathol. 2002 Mar-Apr;5(2):141-50.

PMID:
11910508
40.

Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults.

Manimtim WM, Hasday JD, Hester L, Fairchild KD, Lovchik JC, Viscardi RM.

Infect Immun. 2001 Jun;69(6):3906-15.

41.
42.

Fetal androgen exposure inhibits fetal rat lung fibroblast lipid uptake and release.

Rodriguez A, Viscardi RM, Torday JS.

Exp Lung Res. 2001 Jan - Feb;27(1):13-24.

PMID:
11202061
43.

Effects of hypothermia and hyperthermia on cytokine production by cultured human mononuclear phagocytes from adults and newborns.

Fairchild KD, Viscardi RM, Hester L, Singh IS, Hasday JD.

J Interferon Cytokine Res. 2000 Dec;20(12):1049-55.

PMID:
11152570
45.

Febrile core temperature is essential for optimal host defense in bacterial peritonitis.

Jiang Q, Cross AS, Singh IS, Chen TT, Viscardi RM, Hasday JD.

Infect Immun. 2000 Mar;68(3):1265-70.

46.
47.
48.

Parent perceptions of an NICU follow-up clinic.

Hussey-Gardner BT, Wachtel RC, Viscardi RM.

Neonatal Netw. 1998 Feb;17(1):33-9.

PMID:
9526360
49.

Oleic acid stimulates rapid translocation of cholinephosphate cytidylyltransferase in type II cells.

Viscardi RM, Strauss K, Hasday JD.

Biochim Biophys Acta. 1997 Nov 15;1349(2):157-70.

PMID:
9421188
50.

Cromolyn sodium prophylaxis inhibits pulmonary proinflammatory cytokines in infants at high risk for bronchopulmonary dysplasia.

Viscardi RM, Hasday JD, Gumpper KF, Taciak V, Campbell AB, Palmer TW.

Am J Respir Crit Care Med. 1997 Nov;156(5):1523-9.

PMID:
9372670

Supplemental Content

Loading ...
Support Center